COVID-19

Fatty monocytes in COVID-19

Subjects

Dysfunctional myeloid cells in patients with severe COVID-19 are linked to emergency myelopoiesis, but the exact role of these cells in the disease remains unclear. In this preprint, the authors observed that monocytes from patients with COVID-19 accumulate lipid droplets (LDs). Ex vivo exposure of healthy donor-derived monocytes to SARS-CoV-2 resulted in LD accumulation and upregulation of lipid metabolism targets. Inhibition of LD biogenesis reduced production of pro-inflammatory cytokines, viral replication and death of infected monocytes. Interestingly, the authors also showed that SARS-CoV-2 proteins and double-stranded RNA localize near LDs in infected cells. These results suggest that lipid metabolic reprogramming benefits SARS-CoV-2 infection, and its targeting in myeloid cells may have therapeutic benefit in COVID-19.

References

Original article

  1. Dias, S. S. G. et al. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. Preprint at bioRxiv https://doi.org/10.1101/2020.08.22.262733 (2020)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Matthew D. Park.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Park, M.D. Fatty monocytes in COVID-19. Nat Rev Immunol 20, 649 (2020). https://doi.org/10.1038/s41577-020-00462-2

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing